Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors
November 16, 2017 08:30 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the election of...
Pernix Therapeutics Reports Third Quarter 2017 Financial Results
November 07, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today financial results...
Pernix Therapeutics Announces Sale of Non-Core Product
November 06, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the sale of a...
Pernix Therapeutics to Report Third Quarter 2017 Financial Results on Tuesday, November 7
October 26, 2017 08:00 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today that the Company...
Pernix Therapeutics Announces Planned Departure of Chief Financial Officer
October 17, 2017 16:05 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced that Graham Miao,...
Pernix Therapeutics Reports Second Quarter 2017 Financial Results and Provides Business Update
July 27, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 27, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced financial results...
Pernix Commences Refinancing Transactions to Fortify Balance Sheet
July 20, 2017 16:53 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 20, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today commenced a series of...
Pernix Therapeutics Pre-Announces Certain Preliminary Second Quarter 2017 Financial Results
July 20, 2017 16:52 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 20, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced certain...
Pernix Therapeutics Added to Russell Microcap® Index
June 28, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., June 28, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), announced today that it has been added to the Russell Microcap® index...
Pernix Therapeutics Reports First Quarter 2017 Financial Results and Provides Business Update
May 15, 2017 16:01 ET
|
Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., May 15, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced financial results...